Q2 2017 Holdings
Filed 2017-08-09 | 128 holdings | $63.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $24.4M | 90,000 | 38.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $6.8M | 75,000 | 10.7% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $5.3M | 203,764 | 8.3% |
| Charter Communications Inc N(CHTR) | CL A | 16119P108 | $4.5M | 13,362 | 7.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $4.5M | 161,617 | 7.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.0M | 50,000 | 6.3% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.1M | 257,665 | 4.9% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $3.1M | 200,000 | 4.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $2.8M | 501,000 | 4.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.6M | 217,990 | 4.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.8M | 345,000 | 2.8% |
| Spdr Series TrustPut | PUT | 78464A950 | $43.5K | 5,566 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $32.5K | 250,000 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $20.5K | 320,000 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $19.4K | 450,000 | 0.0% |
| Powershares QQQ TrustPut | PUT | 73935A954 | $17.2K | 1,200 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $16.3K | 230,000 | 0.0% |
| Novartis A G(NVSN) | SPONSORED ADR | 66987V109 | $16.0K | 200,000 | 0.0% |
| Biogen IncCall | CALL | 09062X903 | $14.5K | 500 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $13.8K | 248,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $13.1K | 390,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $12.9K | 383,047 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $12.2K | 100,000 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $11.3K | 68,500 | 0.0% |
| Ituran Location and Control(ITRN) | SHS | M6158M104 | $9.5K | 304,421 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $8.7K | 93,000 | 0.0% |
| Teva Pharmaceutical FIN LLC | DBCV 0.250% 2/0 | 88163VAE9 | $8.6K | 14,535 | 0.0% |
| Tesaro Inc | COM | 881569107 | $7.7K | 55,000 | 0.0% |
| Orbotech LTD | ORD | M75253100 | $7.0K | 213,740 | 0.0% |
| Celgene CorpCall | CALL | 151020904 | $6.8K | 500 | 0.0% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $6.7K | 85,052 | 0.0% |
| Versartis Inc | COM | 92529L102 | $6.6K | 377,524 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $5.9K | 700,000 | 0.0% |
| Mylan N VCall | CALL | N59465909 | $5.8K | 1,500 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $5.6K | 1,100,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $5.4K | 165,700 | 0.0% |
| Visa Inc(V) | COM CL A | 92826C839 | $5.0K | 52,951 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $4.9K | 2,200,000 | 0.0% |
| Facebook Inc(META) | CL A | 30303M102 | $4.9K | 32,167 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $4.9K | 550,000 | 0.0% |
| Union PAC Corp(UNP) | COM | 907818108 | $4.6K | 42,400 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $4.5K | 228,534 | 0.0% |
| Caesarstone LTD(CSTE) | ORD SHS | M20598104 | $4.3K | 122,797 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $4.2K | 473,769 | 0.0% |
| Ignyta Inc | COM | 451731103 | $4.1K | 400,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.1K | 296,310 | 0.0% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $4.1K | 875,931 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $4.1K | 150,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $4.1K | 209,131 | 0.0% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $4.0K | 4,346 | 0.0% |